Personalised Medicine / Population Health and the Preventative Agenda - Who Pays the Bill

Data driven healthcare personalised medicine, population and preventative health have been at the top of the agenda for the discussion in global health systems for several years. But our payor systems are not geared up to fund this activity. This session considers how insurance, outcome-based payment models or government initiatives can be tailored to meet the requirements of the future.

Global Healthcare, the Female Agenda

This session will examine the current state of women’s health in 2025. How big is the gap between male and female healthcare in terms of funding, research, prioritisation and delivery. What are the biggest challenges facing women's healthcare globally and how can we narrow the gender gap?  

Precision Biologics: How AI and Synthetic Biology are Shaping the Future of Medicine

The convergence of AI, synthetic biology and high-throughput biochemistry is revolutionising how we design and produce next-generation therapeutics. In this session, we explore how advancements in enzyme programming, AI-driven molecular design and synthetic platforms are enabling the creation of precision biologics—medicines that are safer, more effective and scalable for global needs. We will discuss how AI accelerates the discovery and optimisation of therapeutic candidates, from biologics to programmable delivery systems, by predicting molecular interactions, programming drug-functions and optimising production pathways. Through real-world case studies, we'll highlight groundbreaking technologies and molecules poised to revolutionise global medicine.

Revolutionising Longevity through Self-Care: Decentralised Diagnostics and Personal AI Co-pilots

Explore how technological innovations are transforming healthcare delivery for an ageing population. This session examines the integration of at-home diagnostics and AI-powered health monitoring systems. Discussion will cover the potential impact on healthcare accessibility, early disease detection, and personalised treatment approaches, whilst addressing implementation challenges and regulatory considerations.

The Future of Longevity Medicine is Here

This presentation examines the revolutionary approach to treating age-related diseases by targeting their root causes. Learn how cutting-edge therapies addressing senescent cells could transform our understanding of aging and disease treatment. The session will explore practical applications in treating conditions like Alzheimer's, diabetes, cancer, and lung fibrosis, offering insights into the future of regenerative medicine.

The Role of Hyperbaric Oxygen Therapy (HBOT) in Health, Performance and Longevity

The topic will explore the transformative role of HBOT in enhancing health, performance, and longevity. It will examine HBOT’s impact on brain health, highlighting its benefits for memory and focus, as well as its role in aiding recovery from brain injuries and neurodegenerative conditions. Additionally, the session will address HBOT’s contribution to long-term health and aging, emphasizing its potential to slow cognitive and physical decline while preventing chronic diseases. Finally, the talk will explore the future of HBOT in medicine, focusing on emerging research and the potential for personalized treatments to further optimize brain and body health, ultimately supporting a healthier and longer life.

Excellence in Quality: Building High-Performance Healthcare Teams

Delivering effective healthcare is about many things. This session explores the nexus between workforce development, clinical planning, technology and service delivery to create high performing healthcare teams, facilities and systems.

The Memory Game - Breaking Down Walls in the Pursuance of a Treatment for Alzheimer’s

Join Dr Emer MacSweeney from leading mental health practitioners Re-Cognition Health as we discuss her work on clinical trials for the first drugs to treat this debilitating condition and her plans to roll them out to patients. We will also be joined by Dr Laila Abdel-Wareth CEO Diagnostics M42 who will discuss the problem and the potential applications of these new treatments in the region.

Automation and its Role in Drug Distribution Locally and Regionally: Benefits, Challenges and Limitations

Gaining from real life experience, we will take the audience into a deep dive of how automation can benefit and streamline the processes within a regional distribution network. In addition, not only will we discuss the challenges faced throughout the process, but we will also offer different ways to overcome them. We will leave the audience with food for thought of the real-life limitations of applying automation and at which point too much automation could yield a negative impact across the supply chain process.

Breaking the Volume Cycle: Building Sustainable Value-based Care Model

As healthcare costs rise while outcomes lag, transitioning from fee-for-service to value-based care is crucial for healthcare sustainability. This session explores essential components for a successful transition, emphasizing a unified data fabric as the foundation for seamless clinical, financial, and operational integration.

Gain actionable insights into implementing value-based care models that improve patient outcomes, reduce costs, enhance provider well-being, and advance population health.

The AI Era: Transforming Patient Experience & Engagement

Traditional healthcare struggles with long wait times, fragmented communication, and lack of personalization. Patients now expect a seamless, patient-centric experience, one that AI enables through real-time support, predictive care and automated engagement, transforming healthcare for the better.

Digital Health: Building Connected Care Ecosystems

 In this session we will consider the technologies, data and capabilities required to create the digital health ecosystem of the future. How do the various apps, technologies, software systems and the people that operate and use them fit together? Six leading digital technologists consider the answer.

The Patient Perspective: What Really Matters in Digital Health

Steve Gardner sits down with Mohammad Al-Ubaydli, CEO of Patients Know Best, digital health expert and author of 7 books around the digital health experience to discuss the role of the patient and their involvement in the digital health ecosystem.

Integrating Digital Health Eco-systems by Using LLM Coaching and Driving the Future of Digital Health Engagement

Explore the cutting edge of digital health and discover how Large Language Models (LLMs) are revolutionising personalised healthcare. Learn how AI-driven systems analyse individual health patterns to create predictive, personalised wellness journeys. Through case studies spanning insurance, banking, and healthcare sectors, see how this technology is moving us from reactive healthcare to proactive health management.

Using Digital Technology to Boost Clinical Productivity

Dive into practical applications of digital technology in clinical settings. This session unveils hands-on strategies for reducing administrative burdens, streamlining documentation, and optimising resource allocation. Through real-world NHS case studies, learn how smart workflow design and digital tools can give healthcare providers more time for patient care.

Healthy Workers, Healthy Companies: How Digital Innovation Transforms Occupational Health and Corporate Well-being

Discover how digital platforms are transforming occupational healthcare from reactive to proactive. Through an innovative combination of physical locations and digital solutions, learn how organisations can provide comprehensive health support for their workforce. Explore how data-driven insights help HR leaders and managers build stronger wellness programmes, reduce absenteeism, and create healthier workplace cultures that drive both employee wellbeing and business success.

Health Regulatory Sandbox

Delve into the concept of regulatory sandboxes as innovative frameworks designed to facilitate the testing of new healthcare technologies and services under regulatory supervision. These sandboxes provide a controlled environment where innovators can experiment with their products while ensuring compliance with safety and efficacy standards. This session will cover how regulatory sandboxes help bridge the gap between rapid technological advancements and existing regulatory frameworks by allowing for real-world testing of new solutions.

Women in Biotech Network: Towards a Sustainable Biotech Ecosystem